metricas
covid
Buscar en
Revista Colombiana de Psiquiatría
Toda la web
Inicio Revista Colombiana de Psiquiatría Prevalencia del consumo de sustancias psicoactivas en pacientes no psiquiátrico...
Journal Information
Vol. 40. Issue 4.
Pages 709-722 (December 2011)
Share
Share
Download PDF
More article options
Vol. 40. Issue 4.
Pages 709-722 (December 2011)
Artículos originales
Full text access
Prevalencia del consumo de sustancias psicoactivas en pacientes no psiquiátricos que consultan un servicio de urgencias en Bogotá
Prevalence of Psychoactive Substance Use in Non-Psychiatric Patients Seen at an Emergency Department in Bogotá
Visits
924
Carlos Gómez-Restrepo1,
Corresponding author
cgomez_restrepo@yahoo.com

Correspondencia: Carlos Gómez-Restrepo, Director Departamento, Epidemiología Clínica y Bioestadística, Hospital Universitario de San Ignacio, Pontificia Universidad Javeriana, Carrera 7ª No. 40-62, piso 2, Bogotá, Colombia
, Sergio Castro-Díaz2, Carolina Eraso Díaz del Castillo3, Fabián Gil4, Carlos Alberto Arango Villegas5, Jenny Fagua6, Juan Carlos Araneda7
1 Médico psiquiatra. Psicoanalista. Epidemiólogo clínico. Profesor, Departamento de Psiquiatría y Salud Mental, y director, Departamento de Epidemiología Clínica y Bioestadística, Pontificia Universidad Javeriana. Bogotá, Colombia
2 Médico residente de primer año de Psiquiatría, Pontificia Universidad Javeriana. Bogotá, Colombia
3 Médica residente de primer año de Psiquiatría, Pontificia Universidad Javeriana. Bogotá, Colombia
4 Estadístico y bioestadístico. Profesor asistente, Departamento de Epidemiología Clínica y Bioestadística, Pontificia Universidad Javeriana. Bogotá, Colombia
5 Médico especialista en medicina familiar, Pontificia Universidad Javeriana. Director, Servicios Ambulatorios, Hospital Universitario de San Ignacio. Bogotá, Colombia
6 Psicóloga. Observatorio de Drogas de Colombia, Ministerio de Justica y del Derecho de Colombia. Bogotá, Colombia
7 Psicólogo. Consultor UNODD
This item has received
Article information
Resumen
Introducción

El consumo de sustancias psicoactivas (SPA) es un problema mundial de salud pública. Los consumidores suelen utilizar los servicios de urgencias, más que los no consumidores.

Objetivo

Determinar la prevalencia de consumo de seis sustancias psicoactivas en personas entre 18 y 65 años, que acudieron al servicio de urgencias de un hospital universitario en Bogotá e identificar sus características demográficas.

Método

Estudio de corte transversal, con muestreo estratificado por grupos de edad y sexo de pacientes adultos que acudieron al servicio de urgencias por patologías no psiquiátricas, a quienes se les aplicó un instrumento que indagaba datos demográficos, médicos, farmacológicos y toxicológicos. Luego se realizó un análisis toxicológico con el Breath Scan Test, para la detección de alcohol a partir de la exhalación de aire, y el Screeners KO, para la detección en orina de cannabinoides, cocaína, benzodiacepinas, anfetaminas y opiáceos, en las últimas seis horas.

Resultados

Se realizó el análisis en 473 personas. La prevalencia de consumo de cualquier sustancia fue de 7,8%. La sustancia más detectada fue opiáceos, seguida por alcohol, cannabis, cocaína, benzodiacepinas y anfetaminas. El reporte verbal de consumo en las últimas seis horas sólo fue veraz para alcohol.

Conclusiones

La prevalencia de consumo de SPA en la población general de urgencias es alta. De acuerdo con los resultados, ocho de cada cien personas que consultan a urgencias han consumido alguna SPA en las últimas seis horas.

Palabras clave:
uso indebido de sustancias
consumidores de drogas
urgencias médicas
prevalencia
Abstract
Introduction

Psychoactive substance abuse is a world public health problem. Drug users tend to use emergency services more than non-users.

Objective

To determine the prevalence and demographic characteristics of the use of six substances in people between the ages of 18 and 65, seen at the emergency department of a teaching hospital in Bogotá.

Method

Cross sectional study with stratified sampling by age and gender groups of adult patients who were seen at the emergency department (ED). Data collected included demographic, medical, pharmacological, and toxicological information. Toxicological analysis was performed with Scan Breath Test to detect alcohol and KO Screeners to screen urine for use of cannabinoids, cocaine, benzodiazepines, amphetamines, and opiates in the last six hours.

Results

Analyses were performed in 473 patients. The prevalence of any substance was 7.8%. The substance most frequently detected was opiates, followed by alcohol, cannabis, cocaine, benzodiazepines, and amphetamines.

Conclusions

The prevalence of psychoactive drug use in the general population of the ED is high. According to these results, 8 of out of 100 people who use emergency services have used a psychoactive substance in the last six hours. The prevalence of self-report was very low compared with the positive results of the toxicology tests.

Key words:
Substance-related disorders
drug users
emergencies
prevalence
Full text is only aviable in PDF
Referencias
[1]
G D'Onofrio, B Becker, RH Woolard.
The impact of alcohol, tobacco, and other drug use and abuse in the emergency department.
Emerg Med Clin North Am, 24 (2006), pp. 925-967
[2]
Schneider Institute for Health Policy.
Substance abuse: the nation's number one health problem. Annual report, Robert Wood Johnson Foundation, (2001),
[3]
Department of Health and Human Services.
Ninth special report to Congress on alcohol and health. National Institute on Alcohol Abuse and Alcoholism, Department of Health and Human Services, (1997),
[4]
NIDA's economic costs of alcohol and drug abuse in the United States, 1992[internet]. 1992 [citado: 11 de agosto del 2011].
[5]
Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Washington, DC; 1989.
[6]
FC Blow, MA Walton, KL Barry, et al.
Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis.
Addict Behav, 36 (2011), pp. 793-800
[7]
CJ Cherpitel.
Drinking patterns and problems associated with injury status in emergency room admissions.
Alcohol Clin Exp Res, 12 (1988), pp. 105-110
[8]
CJ Cherpitel.
Alcohol and injury: a comparison of three emergency room samples in two regions.
J Stud Alcohol, 58 (1997), pp. 323-331
[9]
CA Soderstrom, AL Trifillis, BS Shankar, et al.
Marijuana and alcohol use among 1023 trauma patients. A prospective study.
Arch Surg, 123 (1988), pp. 733-737
[10]
EE Cornwell 3rd, H Belzberg, G Velmahos, et al.
The prevalence and effect of alcohol and drug abuse on cohort-matched critically injured patients.
Am Surg, 64 (1998), pp. 461-465
[11]
G D'Onofrio, LC Degutis.
Screening and brief intervention in the emergency department.
Alcohol Res Health, 28 (2005), pp. 63-72
[12]
M Rondón, C Gómez-Restrepo, J Lozano, et al.
Niveles de alcohol en la sangre y desviación de la línea en conductores estudiados en simuladores.
Rev Colomb Psiquiat, 39 (2010), pp. 235-248
[13]
National Institute of Drug Abuse.
Consensus development panel: drug concentrations and driving impairment.
JAMA, 254 (1985), pp. 2618-2621
[14]
American Academy of Forensic Sciences.
Current Status Report: Drugs And Driving, AAFS, (1988),
[15]
SD Ferrara.
Alcohol, drugs and traffic safety.
Br J Addict, 82 (1987), pp. 871-873
[16]
H Moskowitz.
Marijuana and driving.
Accid Anal Prev, 17 (1985), pp. 323-345
[17]
JF O'Hanlon, TW Haak, GJ Blaauw.
Diazepam impairs lateral position control in highway driving.
Science, 217 (1982), pp. 79-81
[18]
JM Stapleton, S Guthrie, M Linnoila.
Effects of alcohol and other psychoactive drugs on eye movements: relevance to traffic safety.
J Stud Alcohol, 47 (1986), pp. 426-432
[19]
RP Compton, TE Anderson.
The incidence of driving under the influence of drugs, 1985: an update of the state of knowledge. Report no. DOT HS-806 900, Department of Transportation, (1985),
[20]
HWJ Robbe, JF O'Hanlon.
Marijuana, alcohol and actual driving performance. Report no. DOT HS-808 939, Department of Transportation, (1999),
[21]
DW Keer, JD Colliver, AN Kopstein, et al.
Restricted activity days and other problems associated with use of marijuana or cocaine among persons 18–44 years of age: United States, 1991.
Advance data from vital and health statistics, No. 246,
[22]
HWJ Robbe, JF O'Hanlon.
Marijuana and actual driving performance. Report No. DOT HS-808-078, Department of Transportation, (1993),
[23]
SG Vitale, H van de Mheen, A van de Wiel, et al.
Substance use among emergency room patients: Is self-report preferable to biochemical markers?.
Addict Behav, 31 (2006), pp. 1661-1669
[24]
J Mordal, JG Bramness, B Holm, et al.
Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence.
Gen Hosp Psychiatry, 30 (2008), pp. 55-60
[25]
Secretaría Distrital de Salud, Hospital de Occidente de Kennedy.
Alcohol y trauma, Secretaría Distrital de Salud, (1994),
[26]
CJ Cherpitel.
Changes in substance use associated with emergency room and primary care services utilization in the United States general population: 1995–2000.
Am J Drug Alcohol Abuse, 29 (2003), pp. 789-802
[27]
N el-Guebaly, S Armstrong, DC Hodgins.
Substance abuse in the emergency room: Programmatic implications.
J Addict Dis, 17 (1998), pp. 21-31
[28]
BA Smothers, HT Yahr.
Alcohol use disorder and illicit drug use in admissions to general hospitals in the United States.
Am J Addict, 14 (2005), pp. 256-267
[29]
M Soyka.
Substance misuse, psychiatric disorder and violent and disturbed behaviour.
Br J Psychiatry, 176 (2000), pp. 345-350
[30]
M Aguirre-Molina, R Caetano.
Alcohol use and alcohol-related issues.
Latino health in the US: A growing challenge, pp. 393-424
[31]
T Rustøen, AK Wahl, BR Hanestad, et al.
Prevalence and characteristics of chronic pain in the general Norwegian population.
Eur J Pain, 8 (2004), pp. 555-565
[32]
SE Munce, DE Stewart.
Gender differences in depression and chronic pain conditions in a national epidemiologic survey.
Psychosomatics, 48 (2007), pp. 394-399
[33]
R Díaz.
Cómo prevenir en los adolescentes los problemas con las drogas. El adolescente aquí, Club de Pediatría Social, (2005),
[34]
J Lane, D Gerstein, L Huang.
Risk and protective factors for adolescent drug use: Finding from the 1997. SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, (1997),
[35]
AM Rojas.
Factores de riesgo y protectores en el abuso de drogas ilegales en adolescentes jóvenes de Lima Metropolitana, CEDRO, (1999),
[36]
L San, H Carvajal, L Harley, et al.
Factores de riesgo y protectores en el medio universitario costarricense (Investigación cualitativa-grupos focales), Comisión IAFA Universidades. Sub Comisión de Investigación, (1998),
[37]
LD Harrison, SS Martin, T Enev, et al.
Comparing drug testing and self-report of drug use among youths and young adults in the general population (DHHS Publication No. SMA 07-4249, Methodology Series M-7), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, (2007),
[38]
AV Harrell.
The validity of self-reported drug use data: the accuracy of responses on confidential self-administered answered sheets.
NIDA Res Monogr, 167 (1997), pp. 37-58
[39]
FARS 1993–1994. National Highway Traffic Safety Administration.
[40]
D Bailey.
Drug use in patients admitted to a university trauma center.
J Anal Toxicol, 14 (1990), pp. 22-24
[41]
S Pineiro, E Medina, M Rojas.
Prevalencia del consumo de drogas en pacientes atendidos en urgencias de adultos.
Salud Pública de México, 40 (1998), pp. 234-240
[42]
Conace.
Informe de la situación de drogas en Chile Tomo I, Ministerio del Interior, (1999),
[43]
J Bejarano, P Obando.
Trauma y consumo de drogas en pacientes admitidos en salas de emergencia de dos Hospitales generales de Costa Rica.
Salud y Drogas, 2 (2002), pp. 47-60

Conflictos de interés: Los autores manifiestan que no tienen conflictos de interés en este artículo.

Copyright © 2011. Asociación Colombiana de Psiquiatría
Article options